A Comparison of AmBisome(®) to Amphotericin B for Treatment of Systemic Candidiasis in Very Low Birth Weight Infants

PURPOSE: Amphotericin B is considered the treatment of choice for systemic candidiasis, but adverse effects may limit its use. An alternative option for the treatment of candidiasis includes lipid preparations of amphotericin B. This study investigated the safety and efficacy of AmBisome(®), a lipid...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Jeon, Ga Won, Koo, Soo Hyun, Lee, Jang Hoon, Hwang, Jong Hee, Kim, Sung Shin, Lee, Eun Kyung, Chang, Wook, Chang, Yun Sil, Park, Won Soon
Médium: Artigo
Jazyk:Inglês
Vydáno: Yonsei University College of Medicine 2007
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2628045/
https://ncbi.nlm.nih.gov/pubmed/17722233
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2007.48.4.619
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky